DE NOVO EVEROLIMUS- VERSUS MMF-BASED IMMUNOSUPPRESSION IN HEART TRANSPLANT RECIPIENTS: EFFECT ON PROTEINURIA

被引：0
|
作者：
Andreassen, A.
Rinaldi, M.
Gerosa, G.
Bara, C.
Dong, G.
Lopez, P.
Segovia, J.
机构：
[1] Oslo Univ Hosp, Dept Cardiol, Oslo, Norway
[2] Univ Turin, Div Cardiac Surg, San Giovanni Battista Hosp Molinette, Turin, Italy
[3] Univ Padua, Sch Med, Div Cardiac Surg, Dept Cardiac Thorac & Vasc Sci, Padua, Italy
[4] Hannover Med Sch, Dept Cardiac Thorac Transplantat & Vasc Surg, D-3000 Hannover, Germany
[5] Novartis Pharmaceut, Dev, E Hanover, Germany
[6] Novartis Pharma AG, Dev, Basel, Switzerland
[7] Hosp Univ Puerta de Hierro, Unidad Trasplante Cardiaco & Hipertens Pulmonar, Madrid, Spain
来源：
TRANSPLANT INTERNATIONAL | 2011年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：66 / 66
页数：1
相关论文
共 50 条
  • [31] Effect of Everolimus Based Immunosuppression on De Novo Heart Transplant Recipients-24 Months Efficacy and Safety Results from A2310 Study
    Kobashigawa, J.
    Pauly, D.
    Kfoury, A.
    Ross, H.
    Wang, S. -S.
    Cantin, B.
    van Bakel, A.
    Starling, R.
    Hirt, S.
    Dong, G.
    Panis, C.
    Lopez, P.
    Eisen, H.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 67 - 68
  • [32] Calcineurin inhibitor free immunosuppression with everolimus and MMF in maintenance therapy of long term heart transplant recipients
    Vollenbroeker, Beate
    Stypmann, Joerg
    Langer, Claus
    Schmid, Christof
    Suwelack, Barbara
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 203 - 203
  • [33] Comparison of De Novo Everolimus, AZA and MMF in Cyclosporine Based Immunosuppressive Protocol in Pediatric Heart Transplant Patients
    Schubert, S.
    Lehmkuhl, H. B.
    Huebler, M.
    Hetzer, R.
    Berger, F.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (02): : S107 - S107
  • [34] Influence of Everolimus-Based Immunosuppression on Infections in Heart Transplant Recipients
    Ohdah, S.
    Meyer, S.
    Schlueter, M.
    Deuse, T.
    Muellerleile, K.
    Reichenspurner, H.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S190 - S190
  • [35] Early vs. Delayed EVERolimus in De Novo HEART Transplant Recipients
    Potena, L.
    Rinaldi, M.
    Maiello, C.
    Livi, U.
    Gerosa, G.
    Faggian, G.
    Pellegrini, C.
    Musumeci, F.
    Frigerio, M.
    Marraudino, N.
    Porcu, M.
    Veneziano, A.
    Maccherini, M.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S35 - S35
  • [36] De Novo Everolimus-Based Immunosuppression in Liver Transplant Recipients; Retrospective Analysis of Safety and Efficacy.
    Nicolini, Daniele
    Del Pozo, Ana Carolina
    Di Giuseppe, Jacopo
    Vivarelli, Marco
    Garelli, Paolo
    Martorelli, Giacomo
    Vincenzi, Paolo
    Federici, Alen
    Gentili, Marco
    De Luca, Stefano
    Vecchi, Andrea
    Risaliti, Andrea
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 530 - 530
  • [37] IMPACT OF EVEROLIMUS ON PERICARDIAL AND PLEURAL EFFUSIONS IN DE NOVO HEART TRANSPLANT RECIPIENTS
    Barten, M.
    Zuckermann, A.
    Arizon, J. M.
    Dong, G.
    Eisen, H.
    Kobashigawa, J.
    Lehmkuhl, H. B.
    Pellegrini, C.
    Ross, H.
    [J]. TRANSPLANT INTERNATIONAL, 2010, 23 : 8 - 8
  • [38] Everolimus with reduced cyclosporine exposure vs. MMF and conventional cyclosporine:: Results from a study in de novo heart transplant recipients
    Lehmkuhl, H.
    Livi, U.
    Boissonnat, P.
    Arizon, J.
    Vigano, M.
    Magelli, C.
    Almenar, L.
    Abeywickrama, K. H.
    Gezabegen, Y.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (02): : S202 - S202
  • [39] A lower incidence of cytomegalovirus infection in de novo heart transplant recipients randomized to everolimus
    Hill, James A.
    Hummel, Manfred
    Starling, Randall C.
    Kobashigawa, Jon A.
    Perrone, Sergio V.
    Arizon, Jose M.
    Simonsen, Svein
    Abeywickrama, Kamal H.
    Bara, Christoph
    [J]. TRANSPLANTATION, 2007, 84 (11) : 1436 - 1442
  • [40] Everolimus with Reduced CsA vs MMF with Standard CsA Exposure in De Novo Heart Transplant Recipients: 12 Month Efficacy and Safety Analysis
    Eisen, H.
    Pauly, D.
    Starling, R.
    Lehmkuhl, H.
    Ross, H.
    Kfoury, A.
    Wang, S.
    Cantin, B.
    Van Bakel, A.
    Zuckermann, A.
    Lopez, P.
    Dong, G.
    Panis, C.
    Jiang, H.
    Cornu-Artis, C.
    Kobashigawa, J.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S25 - S26
12345